#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Spastic paraplegia-47 (SPG47) is an extremely rare, newly recognized genetic disorder resembling cerebral palsy. It is part of a group of disorders known as hereditary spastic paraplegia (HSP) and is sometimes called “HSP type 47.”
SPG47 is present at birth and causes severe, progressive spasticity and muscle weakness, especially in the lower limbs. In infancy, children with SPG47 have very low muscle tone (hypotonia). As they grow, they develop spasticity (tight, stiff muscles that make movement difficult), together with cognitive deficits.
SPG47 is a recessive disorder caused by two copies of a mutation in a gene called AP4B1, one inherited from each parent. It is thought that these mutations affect the ability of cells in the nervous system to process proteins. Since very few cases have been reported to date, our understanding of the full effects of SPG47 is still emerging.
Virtually all children with SPG47 have:
Other known features of SPG47 can include the following (not every child will have these features):
Because of progressive leg spasticity, children with SPG47 often lose their ability to walk independently, requiring a walker or canes. Many become wheelchair-bound before their teens. Others can walk with a waddling gait. Some children known to have SPG47 have reached their early 20s, but long-term life expectancy for this condition is still unclear, as it was only first recognized in 2011. However, many children with hereditary spastic paraplegias in general have a normal life expectancy.
There is unfortunately no specific treatment for SPG47. However, physical, occupational and speech therapies can help children develop and preserve motor and communication skills. Muscle relaxants and Botox injections can help relieve spasticity in the muscles, and physical therapy can increase strength and range of motion. At Boston Children’s Hospital, we care for patients with spastic paraplegia in the Neuromuscular Center, the Cerebral Palsy Program and the Clinical Genetics program.
Since SPG47 is a recessive disorder, the chances of you and your spouse having another affected child are 1 in 4. Genetic counseling is often helpful if you are planning to have more children.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”